People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...
With an FDA action date of Sept. 26, Bristol Myers Squibb’s KarXT could soon be the first new type of schizophrenia drug in ...
In October 2019, Janet Woodcock, then the director of the US Food and Drug Administration’s Center for Drug Evaluation and ...
On Thursday, the FDA approved Cobenfy, the first medication in decades to fight schizophrenia in a new way FRIDAY, Sept. 27, ...
KHON Honolulu on MSN3d
Kauai Police Department to host Drug Take Back Day on October 26The Kauai Police Department (KPD) is teaming up with the U.S. Drug Enforcement Administration (DEA) to host a Drug Take Back ...
Bristol-Myers Squibb received FDA's approval for Cobenfy, which is poised to be a game changer in the treatment of ...
AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune ...
For years, kratom has been clouded by controversy, largely fueled by media portrayals that paint a negative picture of this ...
Recent development activity and interest there, plus a rezoning of 33 acres from industrial to special development, have ...
The Brooklyn Paper on MSN13d
Drug-impaired wrong-way driver gets 15 years for Williamsburg crash that left woman paralyzedA Long Island man will spend 15 years behind bars for driving recklessly under the influence of drugs and causing a wrong-way collision that left a woman ...
The Korea Times on MSN9d
REDNVIA eyes US market with repurposed drug for heart valve disorderCreating a novel drug has always been a risky endeavor for biopharmaceutical companies. Developers and investors face ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback